Ani işitme kaybında çoklu tedavi yaklaşımın etkinliği
Amaç: Bu çalışmada ani işitme kaybının AİK tedavisinde sistemik steroid ve hiperbarik oksijene HBO ilave olarak intratimpanik steroidin ITS etkinliği araştırıldı.Hastalar ve Yöntemler: Ocak 2008 - Ekim 2011 tarihleri arasında AİK tanısı konulan 58 hasta çalışmaya dahil edildi. Sistemik steroid ve HBO tedavisi uygulanan 20 hasta 11 erkek, 9 kadın; ort. yaş 45.3±21 yıl; dağılım 24-66 yıl grup 1’i oluştururken; sistemik steroid ve HBO tedavisine ek olarak ITS tedavisi uygulanan 38 hasta 19 erkek, 19 kadın; ort. yaş 41.6±16 yıl; dağılım 25-61 yıl grup 2’yi oluşturdu.Bulgular: Tedavi sonrası iyileşme oranları, Siegel kriterlerine göre saf ses ortalamalarında her iki grup arasında istatistiksel olarak anlamlı bulundu p0.05 . Ancak 90 dB üzeri derin işitme kayıplarında güçlü bir istasitiksel fark vardı p
Efficacy of multimodality approach to sudden hearing loss
Objectives: This study aims to investigate whether addition of intratympanic steroid ITS to systemic steroid and hyperbaric oxygen HBO is effective in the treatment of sudden hearing loss SHL . Patients and Methods: Between January 2008 and October 2011, 58 patients diagnosed with SHL were enrolled in the study. Twenty patients 11 males, 9 females; mean age 45.3±21 years; range 24 to 66 years who received systemic steroid and HBO composed group 1, while 38 patients 19 males, 19 females; mean age 41.6±16 years; range 25 to 61 years who received ITS in addition to systemic steroid and HBO composed group 2. Results: Post-treatment hearing improvement was statistically significant in both groups in terms of the mean pure tone according to the Siegel’s criteria p0.05 . However, there was a strong statistically significant difference in terms of profound hearing loss over 90 dB p
___
- Fetterman BL, Saunders JE, Luxford WM. Prognosis and treatment of sudden sensorineural hearing loss. Am J Otol 1996;17:529-36.
- Mattox DE, Simmons FB. Natural history of sudden sensorineural hearing loss. Ann Otol Rhinol Laryngol ;86:463-80.
- Wilson WR, Byl FM, Laird N. The efficacy of steroids
in the treatment of idiopathic sudden hearing loss.
A double-blind clinical study. Arch Otolaryngol
1980;106:772-6.
- Silverstein H, Choo D, Rosenberg SI, Kuhn J, Seidman
M, Stein I. Intratympanic steroid treatment of inner ear
disease and tinnitus (preliminary report). Ear Nose
Throat J 1996;75:468-71.
- Goto F, Fujita T, Kitani Y, Kanno M, Kamei T, Ishii
H. Hyperbaric oxygen and stellate ganglion blocks
for idiopathic sudden hearing loss. Acta Otolaryngol
1979;88:335-42.
- Stokroos RJ, Albers FW, Schirm J. The etiology of
idiopathic sudden sensorineural hearing loss.
Experimental herpes simplex virus infection of the
inner ear. Am J Otol 1998;19:447-52.
- Nagura M, Iwasaki S, Wu R, Mizuta K, Umemura K,
Hoshino T. Effects of corticosteroid, contrast medium
and ATP on focal microcirculatory disorders of the
cochlea. Eur J Pharmacol 1999;366:47-53.
- Tabuchi K, Oikawa K, Uemaetomari I, Tsuji S, Wada T,
Hara A. Glucocorticoids and dehydroepiandrosterone
sulfate ameliorate ischemia-induced injury of the
cochlea. Hear Res 2003;180:51-6.
- Yao X, Buhi WC, Alvarez IM, Curtis LM, Rarey KE. De
novo synthesis of glucocorticoid hormone regulated
inner ear proteins in rats. Hear Res 1995;86:183-8.
- Rarey KE, Luttge WG. Presence of type I and type II/
IB receptors for adrenocorticosteroid hormones in the
inner ear. Hear Res 1989;41:217-21.
- Moskowitz D, Lee KJ, Smith HW. Steroid use in
idiopathic sudden sensorineural hearing loss.
Laryngoscope 1984;94:664-6.
- Dundar K, Gumus T, Ay H, Yetiser S, Ertugrul
E. Effectiveness of hyperbaric oxygen on sudden
sensorineural hearing loss: prospective clinical
research. J Otolaryngol 2007;36:32-7.
- Fujimura T, Suzuki H, Shiomori T, Udaka T, Mori T.
Hyperbaric oxygen and steroid therapy for idiopathic
sudden sensorineural hearing loss. Eur Arch
Otorhinolaryngol 2007;264:861-6.
- Cekin E, Cincik H, Ulubil SA, Gungor A. Effectiveness
of hyperbaric oxygen therapy in management of
sudden hearing loss. J Laryngol Otol 2009;123:609-12.
- Satar B, Hidir Y, Yetiser S. Effectiveness of hyperbaric
oxygen therapy in idiopathic sudden hearing loss. J
Laryngol Otol 2006;120:665-9.
- Parnes LS, Sun AH, Freeman DJ. Corticosteroid
pharmacokinetics in the inner ear fluids: an animal
study followed by clinical application. Laryngoscope
1999;109:1-17.
- Chandrasekhar SS, Rubinstein RY, Kwartler JA, Gatz
M, Connelly PE, Huang E, et al. Dexamethasone
pharmacokinetics in the inner ear: comparison of
route of administration and use of facilitating agents.
Otolaryngol Head Neck Surg 2000;122:521-8.
- Choung YH, Park K, Shin YR, Cho MJ. Intratympanic
dexamethasone injection for refractory sudden
sensorineural hearing loss. Laryngoscope
2006;116:747-52.
- Ho HG, Lin HC, Shu MT, Yang CC, Tsai HT. Effectiveness
of intratympanic dexamethasone injection in suddendeafness patients as salvage treatment. Laryngoscope
2004;114:1184-9.
- . Slattery WH, Fisher LM, Iqbal Z, Friedman RA, Liu
N. Intratympanic steroid injection for treatment of
idiopathic sudden hearing loss. Otolaryngol Head
Neck Surg 2005;133:251-9.
- Haynes DS, O'Malley M, Cohen S, Watford K, Labadie
RF. Intratympanic dexamethasone for sudden
sensorineural hearing loss after failure of systemic
therapy. Laryngoscope 2007;117:3-15.
- Battaglia A, Burchette R, Cueva R. Combination
therapy (intratympanic dexamethasone + high-dose
prednisone taper) for the treatment of idiopathic
sudden sensorineural hearing loss. Otol Neurotol
2008;29:453-60.
- Lautermann J, Sudhoff H, Junker R. Transtympanic
corticoid therapy for acute profound hearing loss. Eur
Arch Otorhinolaryngol 2005;262:587-91.
- Battista RA. Intratympanic dexamethasone for
profound idiopathic sudden sensorineural hearing
loss. Otolaryngol Head Neck Surg 2005;132:902-5.
- Shemirani NL, Schmidt M, Friedland DR. Sudden
sensorineural hearing loss: an evaluation of treatment
and management approaches by referring physicians.
Otolaryngol Head Neck Surg 2009;140:86-91.